Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Developing of Virtual Reality Based Neurologic Examination Teaching Tool(VRNET)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03653221
Recruitment Status : Not yet recruiting
First Posted : August 31, 2018
Last Update Posted : February 12, 2019
Sponsor:
Information provided by (Responsible Party):
Yonsei University

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The purpose of this study is to evaluate the effect of the virtual reality based neurologic examination teaching tool(VRNET) for medical students. VRNET is a new teaching tool for neurologic examinations by offering different neurologic signs of the face, with which medical students can experience more realistic patients.

Condition or disease Intervention/treatment Phase
Medical Students Other: Standard patients with VRNET Other: standard patients Not Applicable

Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 54 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Intervention Model Description:
  1. standardized patients with VRNET
  2. standardized patients
Masking: Double (Investigator, Outcomes Assessor)
Masking Description: investigator, outcome assessors will be blinded for group allocation.
Primary Purpose: Other
Official Title: Developing of Virtual Reality Based Neurologic Examination Teaching Tool(VRNET)
Estimated Study Start Date : March 2019
Estimated Primary Completion Date : August 31, 2019
Estimated Study Completion Date : August 31, 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Health Checkup

Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: standardized patients with VRNET
The medical students examine the standardized patients who have neurological deficits which presented by VRNET.
 Other: Standard patients with VRNET
In group of standard patients with VRNET, the medical students examine the standard patient of neurologic deficits. When they examine, they get some information of neurologic signs via the VRNET which presents neurologic deficits directly by alternating facial expressions. The students should interpret that signs to have a diagnosis.
Placebo Comparator: standardized patients
The medical students examine the standardized patients who have neurological deficits which presented by words or pictures.
 Other: standard patients
In group of standard patients, those neurological deficits are presented only by words or pictures which are not realistic.


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Neurologic physical exam(NPE) score [ Time Frame: after 2 weeks clinical clerkship rotation. ]
    NPE score is consist of 6 neurologic examination parts; cranial nerve, motor, sensory, cerebellar function, gait. Each part has 1 points, so NPE score ranges from 0 to 6. NPE score of students is evaluated by neurologist viewing video clips which recorded during the last day of 2 weeks clerkship rotation.


Secondary Outcome Measures :
  1. Satisfaction of students for VRNET [ Time Frame: after 2 weeks clinical clerkship rotation. ]

    Satisfaction of VRNET are evaluated by students' answer to the question below with Likert scale (0 to 5) after completion examination of standard patient.

    "I am satisfied with VRNET for neurologic examination training. 0 (not at all)---1----2----3-----4-----5 (very helpful)"


  2. Reality of VRNET by students [ Time Frame: after 2 weeks clinical clerkship rotation. ]

    Reality of VRNET are evaluated by students' answer to the question below with Likert scale (0 to 5) after completion examination of standard patient.

    "VRNET is very realistic. 0 (not at all)---1----2----3-----4-----5 (very realistic)"


  3. Evaluation of students by standardized patients [ Time Frame: after 2 weeks clinical clerkship rotation. ]

    Evaluation of students by standard patients is also using Likert scale (0 to 5) based on the pre-made check lists.

    "How do you feel as a standard patient that the student did good job?" 0 (not at all)---1----2----3-----4-----5 (very competent)



Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   23 Years to 30 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • 4th grade medical students of emergency medicine clerkship who agree with participation on this study.

Exclusion Criteria:

  • Disagree with participation on this study.
  • Who are absent the last day of clerkship.
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03653221


Contacts
Layout table for location contacts
Contact: Junho Cho 82-2-2228-2460 ext 82-2-2227-7908 emjh@yuhs.ac

Locations
Layout table for location information
Korea, Republic of
Department of emergency medicine, Yonsei University College of Medicine, Seoul, Korea
Seoul, Korea, Republic of, 03722
Contact: Junho Cho, MD    82-2-2228-2460 ext 82-2-2227-7908    emjh@yuhs.ac   
Sponsors and Collaborators
Yonsei University
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for additonal information
Responsible Party: Yonsei University
ClinicalTrials.gov Identifier: NCT03653221    
Other Study ID Numbers: 4-2018-0665
First Posted: August 31, 2018    Key Record Dates
Last Update Posted: February 12, 2019
Last Verified: February 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No